The portfolio acquired includes Stugeron brand as well as its leading local brands STUGERON FORTE and STUGERON PLUS across 18 markets in the APAC and EMEA regions
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
This marks the fourth acquisition by Corona Remedies from multinational corporations
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
Subscribe To Our Newsletter & Stay Updated
